← Open Payments lookup

JERAD DALTON: Open Payments

NPI 1306835418 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,002 in 121 payments from 19 companies in 2025. Trend: 2023 $8,006 · 2024 $3,237 · 2025 $2,002

Food & beverage: $1,994Education: $8
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc11$271
Supernus Pharmaceuticals, Inc.21$250
Otsuka America Pharmaceutical, Inc.14$236
Vanda Pharmaceuticals Inc.7$191
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$184
Axsome Therapeutics, Inc.10$161
Collegium Pharmaceutical, Inc.16$160
Corium, LLC8$105
Noven Therapeutics, LLC5$92
Neurocrine BioSciences, Inc.3$65

Products named: SPRAVATO, Qelbree, REXULTI, HETLIOZ, CAPLYTA, Jornay PM, Auvelity, Azstarys.

Industry payments across IN — which companies pay providers there.